Altoida announces upcoming poster presentations at AD/PD 2023

Altoida, Inc., a precision neurology company pioneering non-invasive brain health measurement and neurological disease diagnostics with AI and augmented reality ,announced two poster presentations at the upcoming AD/PD 2023 International Conference on Alzheimer's and Parkinson's Diseases and related neurological disorders, on March 28–April 1, 2023 in Gothenburg, Sweden.

Details of the presentations are as follows:

Poster Presentations

Poster Title: Characterization of Cognitive Domains in Individuals with MCI and AD Dementia with The Altoida Digital Neuro Signature (DNS)

Presenter: Alberto Ferrari, Ph.D., Biostatistician, Altoida

Poster Number: P0449* / #2273

Onsite Poster Board Number: 401

Poster Title: Evaluation of The Altoida Digital Neuro Signature (DNS) in Cognitively Normal and MCI Individuals with Hearing Loss – A Pilot Study

Presenter: Florencia Iulita, Ph.D., Head of Medical Strategy and Operations, Altoida

Poster Number: P0450* / #2128

Onsite Poster Board Number: 402

Poster category: A04.J. Imaging, Biomarkers, Diagnostics: Cognitive, Psychometric & Behavioral Tests, Digital Endpoints, Remote Testing

Sign up for our weekly news round-up!

Sign up to the newsletter: In Brief

Sign up for our weekly news round-up!

Sign up for our weekly news round-up!

Sign up to the newsletter: In Brief

I would also like to subscribe to:

Thank you for subscribing